Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684741 | 1.00 | LMNA (0.38) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL29246876 | 1.00 | LMNA (0.38) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL1150595 | 0.83 | LMNA (0.39) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL1150593 | 0.83 | LMNA (0.39) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL1150592 | 0.83 | LMNA (0.39) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL14616414 | 0.83 | LMNA (0.39) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL11231868 | 0.83 | LMNA (0.39) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL10687028 | 0.82 | LMNA (0.36) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL25370678 | 0.81 | LMNA (0.35) | LMNAMAPK1MEN1KMT2ATDP1 | |
| SCHEMBL31695380 | 0.81 | LMNA (0.35) | LMNAMAPK1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1681282-B1 | METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE | SUMITOMO CHEMICAL CO (JP) | 2013-01-23 | — | — | EP | disclosed |
| CN-1874990-B | Method for producing 3,3-dimethyl-2-(1-propenyl)cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| CN-1934063-B | Method for producing (2-formyl-1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL CO | 2010-12-15 | — | — | CN | disclosed |
| US-7700799-B2 | Method for producing (2-formyl-1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-20 | — | — | US | disclosed |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-7498459-B2 | Method for producing (1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-03 | — | — | US | disclosed |
| US-7393971-B2 | Method for producing 3,3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-07-01 | — | — | US | disclosed |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-23 | — | — | US | disclosed |
| US-20070078278-A1 | Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2007-04-05 | — | — | US | disclosed |
| CN-1934063-A | Method for producing (2-formyl-1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL CO (JP) | 2007-03-21 | — | — | CN | disclosed |
| EP-1728781-A1 | PROCESS FOR PRODUCTION OF (1-ALKENYL)CYCLOPROPANES | Sumitomo Chemical Company, Limited (JP) | 2006-12-06 | — | — | EP | disclosed |
| CN-1874990-A | Method for producing 3,3-dimethyl-2-(1-propenyl)cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2006-12-06 | — | — | CN | disclosed |
| EP-1681282-A1 | METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE | Sumitomo Chemical Company, Limited (JP) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | ACSL3, ACSL1, ARL1 | LMNA 2696/4885MAPK1 3685/4885MEN1 2164/4885 |
| US-20070078278-A1 | Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | AOC3, PDXK, AIPL1 | LMNA 2611/4885MAPK1 2182/4885MEN1 446/4885 |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | ACSL3, ARL1, ACSL1 | LMNA 3763/4885MAPK1 2835/4885MEN1 1462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.